Amphetamine Use Revealing Hypertrophic Cardiomyopathy in a Young Patient.
Options
BORIS DOI
Date of Publication
April 2022
Publication Type
Article
Division/Institute
Contributor
Misimi, Vulnet | |
Stamou, Konstantinos | |
Mitsis, Andreas | |
Sakellaropoulos, Panagiotis | |
Tounissidou, Despoina |
Subject(s)
Series
Journal of medical cases
ISSN or ISBN (if monograph)
1923-4163
Publisher
Elmer Press
Language
English
Publisher DOI
PubMed ID
35464329
Uncontrolled Keywords
Description
Adrenergic overstimulation in long term can lead to a hyperdynamic myocardium and give rise to hypertrophy and ultimately to heart failure. Amphetamine use is a common cause of neurohormonal activation, which gives rise to such adverse cardiovascular events. However, hypertrophy of myocardium in young patients, even due to apparently obvious causes, should always be considered as a red flag and a further diagnostic downstream should take place, in order to exclude genetic causes. We present a case of a young man with chronic use of amphetamine and an incidental finding of hypertrophic cardiomyopathy.
File(s)
File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
---|---|---|---|---|---|---|---|
3915-23100-1-PB.pdf | text | Adobe PDF | 494.88 KB | Attribution-NonCommercial (CC BY-NC 4.0) | published |